RT Journal Article
SR Electronic
T1 Early prediction of impending septic shock in children using age-adjusted Sepsis-3 criteria
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.30.20241430
DO 10.1101/2020.11.30.20241430
A1 Ran Liu
A1 Joseph L. Greenstein
A1 James C. Fackler
A1 Jules Bergmann
A1 Melania M. Bembea
A1 Raimond L. Winslow
YR 2020
UL http://medrxiv.org/content/early/2020/12/02/2020.11.30.20241430.abstract
AB Sepsis is a syndrome which afflicts both adults and children, with many disease courses and diverse outcomes. Understanding of sepsis pathophysiology has changed over time; the Sepsis-3 criteria define sepsis in adults as organ dysfunction, quantified by SOFA score, caused by dysregulated immune response to infection. However, pediatric consensus definitions still utilize the SIRS-based Sepsis-2 criteria, though individual groups have attempted to adapt the Sepsis-3 criteria for children. We evaluate age-adjusted Sepsis-3 criteria on 2,384 pediatric patients admitted to the Johns Hopkins PICU, and apply previously-published methods for early prediction of septic shock. We obtain best early prediction performance of 0.96 AUC, 49.9% overall PPV, and a 5.8-hour median EWT using Sepsis-3 labels based on age-adjusted SOFA score. Through analyses of risk score evolution over time, we corroborate our past finding of an abrupt transition preceding onset of septic shock in children, and are able to stratify pediatric sepsis patients using their first post-threshold-crossing risk score.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWork supported by NSF EECS 1609038 and NIH UL1 TR001079.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Johns Hopkins Medicine IRB https://www.hopkinsmedicine.org/institutional_review_board/All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData referred to in this manuscript are not publicly available.